Jeffrey Segal is Director of INVO Bioscience, Inc.. Currently has a direct ownership of 28,220 shares of INVO, which is worth approximately $20,318. The most recent transaction as insider was on Jun 01, 2022, when has been sold 9,211 shares (Common Stock) at a price of $0.95 per share, resulting in proceeds of $8,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.2K
0% 3M change
0% 12M change
Total Value Held $20,318

Jeffrey Segal Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 01 2022
BUY
Open market or private purchase
$8,750 $0.95 p/Share
9,211 Added 24.61%
28,220 Common Stock
Jan 15 2022
BUY
Grant, award, or other acquisition
-
8,034 Added 30.85%
18,009 Common Stock
Dec 31 2020
BUY
Grant, award, or other acquisition
-
8,838 Added 46.98%
9,975 Restricted Stock
Nov 27 2020
BUY
Grant, award, or other acquisition
-
1,137 Added 50.0%
1,137 Common Stock
JS

Jeffrey Segal

Director
Sarasota, FL

Track Institutional and Insider Activities on INVO

Follow INVO Bioscience, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INVO shares.

Notify only if

Insider Trading

Get notified when an Invo Bioscience, Inc. insider buys or sells INVO shares.

Notify only if

News

Receive news related to INVO Bioscience, Inc.

Track Activities on INVO